Detalhe da pesquisa
1.
Acute Left Ventricular Dysfunction Following Gemtuzumab Ozogamicin in Two Pediatric AML Patients.
J Pediatr Hematol Oncol
; 44(2): e507-e511, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35200224
2.
Convalescent plasma for pediatric patients with SARS-CoV-2-associated acute respiratory distress syndrome.
Pediatr Blood Cancer
; 67(11): e28693, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32885904
3.
Sinusoidal Obstruction Syndrome During Maintenance Therapy for Acute Lymphoblastic Leukemia With 6-Mercaptopurine and Methotrexate: A Pediatric Case Report.
J Pediatr Hematol Oncol
; 39(8): e454-e455, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28085749
4.
INSPIRED Symposium Part 5: Expanding the Use of CAR T Cells in Children and Young Adults.
Transplant Cell Ther
; 2024 Apr 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38588880
5.
Practice Preferences for Consolidative Hematopoietic Stem Cell Transplantation Following Tisagenlecleucel in Children and Young Adults with B Cell Acute Lymphoblastic Leukemia.
Transplant Cell Ther
; 30(1): 75.e1-75.e11, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37816472
6.
INSPIRED Symposium Part 3: Prevention and Management of Pediatric Chimeric Antigen Receptor T Cell-Associated Emergent Toxicities.
Transplant Cell Ther
; 30(1): 38-55, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37821079
7.
Clinical Trials on Cellular Therapy for Children and Adolescents With Cancer: A 15-Year Trend in the United States.
Cureus
; 15(10): e47885, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-38021600
8.
HLH-like toxicities predict poor survival after the use of tisagenlecleucel in children and young adults with B-ALL.
Blood Adv
; 7(12): 2758-2771, 2023 06 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36857419
9.
Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome.
Transplant Cell Ther
; 29(7): 438.e1-438.e16, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36906275
10.
Mediport use as an acceptable standard for CAR T cell infusion.
Front Immunol
; 14: 1239132, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37965315
11.
Potential Role of IFNγ Inhibition in Refractory Cytokine Release Syndrome Associated with CAR T-cell Therapy.
Blood Cancer Discov
; 3(2): 90-94, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35015687
12.
Xenograft models for pediatric cancer therapies.
Fac Rev
; 10: 11, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33659929
13.
Proteomic profiling of MIS-C patients indicates heterogeneity relating to interferon gamma dysregulation and vascular endothelial dysfunction.
Nat Commun
; 12(1): 7222, 2021 12 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34893640
14.
Proteomic Profiling of MIS-C Patients Reveals Heterogeneity Relating to Interferon Gamma Dysregulation and Vascular Endothelial Dysfunction.
medRxiv
; 2021 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33907759
15.
Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) Antibody Responses in Children With Multisystem Inflammatory Syndrome in Children (MIS-C) and Mild and Severe Coronavirus Disease 2019 (COVID-19).
J Pediatric Infect Dis Soc
; 10(5): 669-673, 2021 May 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-33263756
16.
Deep immune profiling of MIS-C demonstrates marked but transient immune activation compared to adult and pediatric COVID-19.
Sci Immunol
; 6(57)2021 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33653907
17.
Enhancing Neuroblastoma Immunotherapies by Engaging iNKT and NK Cells.
Front Immunol
; 11: 873, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32457760
18.
Evidence of thrombotic microangiopathy in children with SARS-CoV-2 across the spectrum of clinical presentations.
Blood Adv
; 4(23): 6051-6063, 2020 12 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33290544
19.
SARS-CoV-2 antibody responses in children with MIS-C and mild and severe COVID-19.
medRxiv
; 2020 Aug 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32839782
20.
Deep Immune Profiling of MIS-C demonstrates marked but transient immune activation compared to adult and pediatric COVID-19.
medRxiv
; 2020 Oct 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32995826